Kevin Lee Freeman, Chief Commercial Officer at Health Catalyst, Inc. (HCAT), sold 10,272 shares at $7.22 ($74K) on 2024-09-03, disclosed to the SEC on 2024-09-05.
Open-market sale of $74k HCAT by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.22 | 7,500 | $54K | 72.9% |
| 2 | $7.27 | 2,772 | $20K | 27.1% |
| Total | $7.23 avg | 10,272 | $74K | 100% |
| Filing → |